✦ LIBER ✦

Vinorelbine-based salvage therapy in HER2-positive metastatic breast cancer patients progressing during trastuzumab-containing regimens: a retrospective study

✍ Scribed by Filippo Montemurro; Stefania Redana; Franco Nolè; Michela Donadio; Maria Elena Jacomuzzzi; Giorgio Valabrega; Giuseppe Viale; Anna Sapino; Massimo Aglietta

Book ID: 115011312
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 285 KB
Volume: 8
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-8-209

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retrospective Evaluation of Clinical Out

Retrospective Evaluation of Clinical Outcomes in Patients with HER2-Positive Advanced Breast Cancer Progressing on Trastuzumab-Based Therapy in the Pre-Lapatinib Era

✍ Filippo Montemurro; Stefania Redana; Giuseppe Viale; Giuseppina Sanna; Michela D 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 123 KB

A phase II study of afatinib (BIBW 2992)

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

✍ Nancy U. Lin, Eric P. Winer, Duncan Wheatley, Lisa A. Carey, Stephen Houston, Da 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 218 KB

Benefit of continuing trastuzumab beyond

Benefit of continuing trastuzumab beyond progression in her2-positive metastatic breast cancer (mbc) is independent of the chemotherapy partner: message from a single-centre retrospective study

✍ Raffaella Palumbo; Federico Sottotetti; Antonio Bernardo; Maria Rosa Strada; Alb 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 60 KB